Release of our first CSR Report!
We’re excited to announce the publication of our first CSR Report!
Press releases
February 28, 2022
Montagu as new investor
February 28, 2022
HTL announces that Montagu, a leading private equity firm, has acquired a majority stake of HTL previously held by Bridgepoint. The other minority shareholders, Naxicap and Téthys Invest, will keep their shares in the company.
The arrival of this new shareholder symbolizes the international success of a company that has become the world leader in the development and production of pharmaceutical grade biopolymers.
To see our most recent news,
follow us on LinkedIn
Read more
news from us
-
Articles February 25, 2025Our participation at PCHI in China
As a global company, we were delighted to participate in Personal Care and Homecare Ingredients (PCHi) 2025 in Guangzhou, China this year.
-
Articles February 1, 2025HTL Biotechnology at IMCAS 2025
HTL Biotechnology made a strong impact this year at IMCAS with a reinforced presence and exciting interactions with our customers and partners.
-
Articles January 24, 2025Certification ISO 13485
We’re happy to share that HTL Biotechnology got the new certification ISO 13485.